Related Experiment Video
Updated: Nov 29, 2025
06:19
Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
3.6K
Barbiturate derivatives for managing multifaceted oncogenic pathways: A mini review
Parteek Prasher1,2, Mousmee Sharma1,3, Samarth P Singh2
1UGC Sponsored Centre for Advanced Studies, Department of Chemistry, Guru Nanak Dev University, Amritsar, India.
Drug Development Research
|November 19, 2020
Summary
Barbiturates show anticancer potential by targeting multiple cancer pathways. Derivatives offer a hybrid approach to manage complex cancer progression and drug resistance.
Area of Science:
- Oncology
- Medicinal Chemistry
Background:
- Metastasis involves complex, synchronized pathway dysregulation, challenging conventional anticancer therapies.
- Drug resistance and pathway interplay exacerbate cancer complexity.
Purpose of the Study:
- To collate the role of barbiturates and their derivatives in managing cancer-associated pathways.
- To explore barbiturates as potential agents against complex cancer mechanisms.
Main Methods:
- Review of literature on barbiturates and their derivatives in cancer research.
- Analysis of barbiturate activity against key cancer pathways (e.g., MMPs, HDACs, Ras/MAPK).
Main Results:
- Barbiturates demonstrate anticancer activity by attenuating critical metabolic and enzymatic pathways.
- Derivatization and conjugation create hybrid molecules with enhanced profiles for pathway management.
Conclusions:
- Barbiturates and their derivatives represent a promising strategy for targeting multiple cancer pathways.
- These compounds offer a potential avenue for overcoming drug resistance and managing metastatic disease.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
2.4K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.4K
01:10Drugs that Destabilize Microtubules
2.3K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.3K
02:57Targeted Cancer Therapies
8.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.2K
02:50Combination Therapies and Personalized Medicine
5.6K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
02:49Cancer Therapies
9.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.3K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
397
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
397